Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU project confirms Europe's excellence in migraine research

07.11.2007
An EU-funded project on migraines has not only taken researchers a step closer to understanding the causes of these incapacitating attacks, but has created a critical mass, reinforcing Europe's reputation of excellence in this field, and reassuring migraine sufferers that their condition is being taken seriously.

Over 12% of the world's population suffer from migraines, with women making up two-thirds of sufferers. The attacks are not only highly unpleasant for sufferers, but are also costly for employers and health services. Annual costs are estimated at €10 billion for the EU alone.

Although the problem is widespread, the available treatments are unsuccessful in more than half of patients. The migraine community is therefore desperate for possible treatments, and has demonstrated this by participating in EUROHEAD's research.

Coordinators of the recently-concluded EU-funded project EUROHEAD spoke to CORDIS News about the discoveries made in the project and the impact that it has had on the migraine research community worldwide.

A cure for migraines is still some way off, but the EUROHEAD team does now have a much better understanding of how genes are involved in the triggering of a migraine, and how the trigger threshold can be reduced.

There is compelling evidence that cortical spreading depression (CSD) is responsible for the 'aura', the visual disturbances that often accompany migraines. The EUROHEAD team now believes that it could also be responsible for the onset of migraines themselves.

Several thousand migraine patients participated in the research, including twins and families in which migraines are common. Crucial to the success of the project was the involvement of people who suffer from a monogenic subtype of migraine, in which one sole gene is responsible for the condition. Five or six years ago there was just one pool of patients with the monogenic migraine subtype. The EUROHEAD team has now identified far more families in which the condition runs, and has also identified new syndromes.

Much of the research was done using cellular models, but animal models and human volunteers were also involved. Cellular models enabled the team to see what effects the genes had on cells at microscopic level. When investigating how the cells interact, the animal models were needed. 'We could never have done this if we had stuck to single cells. The two models were complimentary,' explains Dr Arn van den Maagdenberg of Leiden University Medical Centre in the Netherlands.

Brave volunteers in Denmark had an attack triggered by a team at Glostrup University Hospital using nitric oxide. The method developed in Glostrup is successful in triggering migraines in 60% to 70% of sufferers. Asked about these volunteers' readiness to have a migraine triggered in the name of science, Principal Investigator Michel Ferrari was very positive: 'The migraine population as a whole is very happy with initiatives like this. They feel they are being taken seriously. It has been established that this is a real disease,' he says.

While EUROHEAD has shown migraine-sufferers that they are being taken seriously, it has also indicated to the world that Europe should be taken seriously as a centre of excellence for migraine research. 'Europe is already the centre of excellence for migraine research. It is striking that, in other medical areas, the US is leading, but not in this area,' says Dr Ferrari. Moreover, most of the important research groups in this field were members of the EUROHEAD consortium.

The team has been contacted by researchers in every continent interested in collaborating on future research. Many have even sent genetic material from new families of migraine-sufferers. The EUROHEAD team is following up on the invitations that it has received, and many joint publications are in the pipeline.

EUROHEAD is currently experiencing what Dr van den Maagdenberg refers to as the 'magnet effect'. 'Everybody's looking at EUROHEAD as the experts on migraines,' he said.

Dr van den Maagdenberg welcomes the critical mass, the integration of research teams and the momentum created by EUROHEAD. When the right call is published under the EU's Seventh Framework Programme (FP7), the team will apply for further funding with the ultimate aim of finding a cure for the migraine.

Virginia Mercouri | alfa
Further information:
http://www.eurohead.org/
http://cordis.europa.eu/news

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>